![Ileen B. Winick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ileen B. Winick
Human Resources Officer bij
CANDEL THERAPEUTICS, INC.
Profiel
Ileen B. Winick currently works at Candel Therapeutics, Inc., as Chief People Officer from 2021.
Ms. Winick also formerly worked at Casebia Therapeutics LLC, as Senior Vice President-Human Resources.
Ms. Winick received her graduate degree from Cornell University and undergraduate degree from the University of Cincinnati (Ohio).
Actieve functies van Ileen B. Winick
| Bedrijven | Functie | Begin |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Human Resources Officer | 01-01-2021 |
Eerdere bekende functies van Ileen B. Winick
| Bedrijven | Functie | Einde |
|---|---|---|
Casebia Therapeutics LLC
 Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Discovers, develops and commercializes gene-editing therapeutics to treat the genetic causes of bleeding disorders, autoimmune disease | Human Resources Officer | - |
Opleiding van Ileen B. Winick
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
3
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cincinnati (Ohio)
 University of Cincinnati (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Discovers, develops and commercializes gene-editing therapeutics to treat the genetic causes of bleeding disorders, autoimmune disease | Health Technology |
